This article is available to subscribers. Subscribe now. Already have an account? Sign in

EditorialFree Preview

REVIVE-ing a Weak Heart — Details Matter

List of authors.
  • Ajay J. Kirtane, M.D.

Ischemic cardiomyopathy represents the pathophysiological convergence of two growing clinical problems: atherosclerotic coronary artery disease and congestive heart failure. When a patient presents with congestive heart failure, it is incumbent on clinicians to undertake an etiologic workup that includes evaluation for a diagnosis of coronary artery disease1; simply establishing a diagnosis of coronary artery disease has been associated with greater use of guideline-directed medical therapies among patients with congestive heart failure.2 When it is severe, coronary artery disease is often assumed to be the cause of left ventricular dysfunction. Apart from the accuracy of that assumption, a further open question . . .

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the author are available with the full text of this editorial at NEJM.org.

This editorial was published on August 27, 2022, at NEJM.org.

Author Affiliations

From the Columbia University Irving Medical Center, New York–Presbyterian Hospital, and the Cardiovascular Research Foundation — both in New York.